China-based in vitro diagnostic (IVD) company Fapon Biotech has announced a strategic investment with the establishment of a new manufacturing facility in West Java, Indonesia. The expansion is part of the company’s global growth initiative and will be operationalized through its subsidiary, PT Fapon Bioindustries Indonesia (PT Fapon).
Specializing in integrated solutions and services for the diagnostics, biopharma, and biotherapy sectors, Fapon Biotech is committed to bringing the latest advancements in IVD products to the Indonesian market. The new facility is expected to enhance the company’s production capabilities and strengthen its position as a leading provider of diagnostic solutions in the region.- Flcube.com
